Literature DB >> 19321862

Expression of Scl in mesoderm rescues hematopoiesis in the absence of Oct-4.

Kimi Y Kong1, Elizabeth A Williamson, Jason H Rogers, Tam Tran, Robert Hromas, Richard Dahl.   

Abstract

In embryonic stem cells, Oct-4 concentration is critical in determining the development of endoderm, mesoderm, and trophectoderm. Although Oct-4 expression is essential for mesoderm development, it is unclear whether it has a role in the development of specific mesodermal tissues. In this study, we have examined the importance of Oct-4 in the generation of hematopoietic cells using an inducible Oct-4 ESC line. We demonstrate that Oct-4 has a role in supporting hematopoiesis after specifying brachyury-positive mesoderm. When we suppressed Oct-4 expression before or after mesoderm specification, no hematopoietic cells are detected. However, hematopoiesis can be rescued in the absence of Oct-4 after mesoderm specification if the essential hematopoietic transcription factor stem cell leukemia is expressed. Our results suggest that, for hematopoiesis to occur, Oct-4 is required for the initial specification of mesoderm and subsequently is required for the development of hematopoietic cells from uncommitted mesoderm.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19321862      PMCID: PMC2710954          DOI: 10.1182/blood-2008-08-174755

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  14 in total

1.  Involvement of Oct3/4 in the enhancement of neuronal differentiation of ES cells in neurogenesis-inducing cultures.

Authors:  Koji Shimozaki; Kinichi Nakashima; Hitoshi Niwa; Tetsuya Taga
Journal:  Development       Date:  2003-06       Impact factor: 6.868

2.  Oct4 RNA interference induces trophectoderm differentiation in mouse embryonic stem cells.

Authors:  J Matthew Velkey; K Sue O'Shea
Journal:  Genesis       Date:  2003-09       Impact factor: 2.487

3.  Quantitative Oct4 overproduction in mouse embryonic stem cells results in prolonged mesoderm commitment during hematopoietic differentiation in vitro.

Authors:  Valérie Camara-Clayette; Françoise Le Pesteur; William Vainchenker; Françoise Sainteny
Journal:  Stem Cells       Date:  2006-05-11       Impact factor: 6.277

4.  A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo.

Authors:  M H Rosner; M A Vigano; K Ozato; P M Timmons; F Poirier; P W Rigby; L M Staudt
Journal:  Nature       Date:  1990-06-21       Impact factor: 49.962

5.  Hematopoietic-specific genes are not induced during in vitro differentiation of scl-null embryonic stem cells.

Authors:  A G Elefanty; L Robb; R Birner; C G Begley
Journal:  Blood       Date:  1997-08-15       Impact factor: 22.113

6.  Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells.

Authors:  H Niwa; J Miyazaki; A G Smith
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

7.  New type of POU domain in germ line-specific protein Oct-4.

Authors:  H R Schöler; S Ruppert; N Suzuki; K Chowdhury; P Gruss
Journal:  Nature       Date:  1990-03-29       Impact factor: 49.962

8.  A common precursor for hematopoietic and endothelial cells.

Authors:  K Choi; M Kennedy; A Kazarov; J C Papadimitriou; G Keller
Journal:  Development       Date:  1998-02       Impact factor: 6.868

9.  A transitional stage in the commitment of mesoderm to hematopoiesis requiring the transcription factor SCL/tal-1.

Authors:  S M Robertson; M Kennedy; J M Shannon; G Keller
Journal:  Development       Date:  2000-06       Impact factor: 6.868

10.  Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells.

Authors:  Y I Yeom; G Fuhrmann; C E Ovitt; A Brehm; K Ohbo; M Gross; K Hübner; H R Schöler
Journal:  Development       Date:  1996-03       Impact factor: 6.868

View more
  4 in total

1.  Dual roles of Oct4 in the maintenance of mouse P19 embryonal carcinoma cells: as negative regulator of Wnt/β-catenin signaling and competence provider for Brachyury induction.

Authors:  Yusuke Marikawa; Dana Ann A Tamashiro; Toko C Fujita; Vernadeth B Alarcon
Journal:  Stem Cells Dev       Date:  2011-01-08       Impact factor: 3.272

2.  Interaction of retinoic acid and scl controls primitive blood development.

Authors:  Jill L O de Jong; Alan J Davidson; Yuan Wang; James Palis; Praise Opara; Emily Pugach; George Q Daley; Leonard I Zon
Journal:  Blood       Date:  2010-04-21       Impact factor: 22.113

3.  The miR-23a~27a~24-2 microRNA cluster buffers transcription and signaling pathways during hematopoiesis.

Authors:  Jeffrey L Kurkewich; Justin Hansen; Nathan Klopfenstein; Helen Zhang; Christian Wood; Austin Boucher; Joseph Hickman; David E Muench; H Leighton Grimes; Richard Dahl
Journal:  PLoS Genet       Date:  2017-07-13       Impact factor: 5.917

4.  The pluripotency factor NANOG controls primitive hematopoiesis and directly regulates Tal1.

Authors:  Julio Sainz de Aja; Sergio Menchero; Isabel Rollan; Antonio Barral; Maria Tiana; Wajid Jawaid; Itziar Cossio; Alba Alvarez; Gonzalo Carreño-Tarragona; Claudio Badia-Careaga; Jennifer Nichols; Berthold Göttgens; Joan Isern; Miguel Manzanares
Journal:  EMBO J       Date:  2019-02-27       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.